Internal Medicine, Hematology & Oncology · New Haven, CT
NPI
1730454232
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
333 Cedar St # 205
New Haven, CT, 06510
Phone (203) 785-4095
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
380 services
Medicare patients, 2024
179
Average age 75
Drug cost, 2024
$339K
430 prescriptions
Company payments, 2025
$13K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cheryl Mensah was code 99214 (office e&m - established), 165 times for 79 patients. In total Cheryl Mensah billed 380 services in 14 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 165 | 79 | $125.02 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 132 | 74 | $75.43 | $9,957 |
| 99204 Office E&M - New | Office | 24 | 23 | $164.54 | $3,949 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $165.56 | $2,649 |
| 99205 Office E&M - New | Office | 15 | 15 | $216.98 | $3,255 |
By year: 2022 $31K for 384 services; 2023 $23K for 268 services; 2024 $42K for 380 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cheryl Mensah prescribed most often to Medicare patients was Eliquis (Apixaban), with 73 prescriptions and refills. In total Cheryl Mensah wrote 430 Medicare prescriptions that cost $339K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 73 | 81 | 15 | $46K |
| Hydroxyurea Generic | 51 | 51 | 11 | $931 |
| Oxycodone Hcl Generic | 27 | 27 | Under 11 | $1,118 |
| Xarelto Rivaroxaban | 20 | 30 | Under 11 | $16K |
| Methadone Hcl Generic | 18 | 18 | Under 11 | $551 |
| Ondansetron Odt Ondansetron | 17 | 17 | Under 11 | $246 |
| Diphenhydramine Hcl Generic | 16 | 18 | Under 11 | $67.88 |
| Hydromorphone Hcl Generic | 16 | 16 | Under 11 | $298 |
| Oxycontin Oxycodone Hcl | 12 | 12 | Under 11 | $13K |
| Adakveo Crizanlizumab-Tmca | 11 | 11 | Under 11 | $76K |
Brand drugs: 155 claims; generic drugs: 275 claims; opioid claims: 96.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cheryl Mensah $13K ($13K in general payments such as food, travel and fees) from 3 companies. The largest payer was Vertex Pharmaceuticals Incorporated with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.